NSE · VIJAYPD · Retail
Vijaypd Ceutical Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹118 Cr with net profit ₹5 Cr — a 4.07% net margin, versus 2.79% the period before.
Shareholding
As of 2026-03-31
- Promoter56.43%
- Public43.57%
380 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 3.27× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Trading · ranked #1 of 666 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Adani Enterprises Limited | ₹3,93,459 Cr | 24.35 | 4.83 | 3.42% | 9.3% |
| Avenue Supermarts Limited | ₹2,50,959 Cr | 381.38 | 10.26 | 12.14% | 4.32% |
| Trent Ltd. | ₹1,60,247 Cr | 92.84 | 22.94 | 24.62% | 8.57% |
| FSN E-Commerce Ventures Ltd. | ₹93,790 Cr | 1212.96 | 65.21 | 13.87% | 1.99% |
| Vishal Mega Mart Limited | ₹50,703 Cr | 56.97 | 6.83 | 11.32% | 6.61% |
| Premier Energies Limited | ₹47,038 Cr | 102.19 | 10.9 | 35.05% | 19.3% |
| Aegis Logistics Limited | ₹45,019 Cr | 109.72 | 7.44 | 14.83% | 10.78% |
| Aditya Infotech Limited | ₹40,364 Cr | 238.34 | 21.5 | 19.61% | 8.72% |
| Redington Limited | ₹22,472 Cr | 57.38 | 2.21 | 14.67% | 1.25% |
| Honasa Consumer Limited | ₹14,620 Cr | 210.96 | 10.36 | 14.16% | 8.36% |
| Vijaypd Ceutical Limited(this company) | — | 25.1 | 2.42 | — | — |
AI analysis
AI-generated · google/gemini-2.5-flashVijaypd Ceutical Limited reported revenue of Rs 117.87 Cr and a net profit of Rs 4.7955 Cr in the latest annual results. The company has an EPS of 2.59 and a PE ratio of 25.98. The promoter holding stands at 56.4333% as of March 31, 2026.
Positives
- +Revenue increased from Rs 59.2205 Cr in Mar 2024 to Rs 117.8731 Cr in Mar 2025.
- +Net profit rose from Rs 1.6502 Cr in Mar 2024 to Rs 4.7955 Cr in Mar 2025.
- +Return on capital employed (ROCE) is 20.35%.
Negatives
- −The promoter shareholding decreased from 81.8657% in July 2025 to 56.4333% in March 2026.
- −The debt-to-equity ratio of 1.19 indicates a relatively high reliance on debt financing.
- −No quarterly results have been disclosed.
Financial Performance
Vijaypd Ceutical Limited's revenue increased to Rs 117.8731 Cr in March 2025 from Rs 59.2205 Cr in March 2024. Net profit also rose to Rs 4.7955 Cr in March 2025, compared to Rs 1.6502 Cr in March 2024. EPS for March 2025 was 3.84, up from 8.25 in March 2024 (Note: EPS figures should be reviewed in conjunction with potential stock splits or changes in outstanding shares).
Profitability & Returns
The company recorded a return on capital employed (ROCE) of 20.35%. EBITDA grew to Rs 8.6749 Cr in March 2025 from Rs 4.5356 Cr in March 2024, indicating improved operational efficiency. The EPS for the latest period is 2.59.
Balance Sheet
Vijaypd Ceutical Limited has a book value of Rs 26.9. The debt-to-equity ratio is 1.19, which indicates the extent of debt financing relative to equity. Further details on the balance sheet structure would require additional data.
Ownership & Pledges
As of March 31, 2026, the promoter holding in Vijaypd Ceutical Limited was 56.4333%. Public shareholding stood at 43.5667%. There was no promoter pledging reported as of the latest available data. The number of shareholders as of March 31, 2026 was 380.
Regulatory & Surveillance
No specific information regarding regulatory actions or surveillance measures was provided in the available data for Vijaypd Ceutical Limited. Investors should independently verify compliance and any potential regulatory impacts.
Data as of — price: 2026-07-29 · financials: Mar 25 · shareholding: Mar 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.